InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.92
(
0.08%
)
Bitcoin
62,179.28
(
2.12%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

BTH

Send PM Follow Ignore
Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: None

Monday, 09/27/2010 7:20:41 PM

Monday, September 27, 2010 7:20:41 PM

Post# of 80490
From the abstract:

"however, these patients (n=2) were not included in this unplanned interim analysis" (it was unblinded back in March of 2010)

I wonder if they unblinded this data (as they called it "unplanned") to get a read on whether it was a valid drug BEFORE they agreed to revise the Ariad-Merck Agreement?

Likely, IMO.

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up